. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000 Aug;6(8):916-9. PubMed.


Please login to recommend the paper.


  1. A critical initial study for validating immunotherapy of AD.

Make a Comment

To make a comment you must login or register.